Publication | Closed Access

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained

Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematologyStat3 ActivationPathologyJak2 V617fAdult T-cell Leukemia-lymphomaMolecular DiagnosticsCell BiologyCancer ResearchTumor BiologyJak-stat Signaling PathwayMyeloid Neoplasia